Argen X SE
Sector: Manufacturing
Industry: Pharmaceutical Products
596.20
8.61
(1.47%)
Volume:
321,814
52 week range:
352.77 - 678.21
Market Cap:
36.226B
Company Description:
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases. Its lead product candidate is efgartigimod for the. treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy. The company is also developing immunology innovation programs, including cusatuzumab for hematological cancer, as well as high risk MDS.